Volume 14, Issue 4 (2012)
mjms 2012, 14(4): 13-20 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Baesi K, Ravanshad M, Ghanbari Safari M, Saberfar E, Hajiabdolbaghi M. Survey of Human Immunodeficiency Virus-1 Protease Gene Drug Resistance among HIV-infected Patients in an Iranian Research Center for HIV/AIDS. mjms 2012; 14 (4) :13-20
URL: http://mjms.modares.ac.ir/article-30-3635-en.html
URL: http://mjms.modares.ac.ir/article-30-3635-en.html
Kazem Baesi1 
, Mehrdad Ravanshad 1, Maryam Ghanbari Safari2 , Esmaeil Saberfar3 , Mahboubeh Hajiabdolbaghi4
, Mehrdad Ravanshad 1, Maryam Ghanbari Safari2 , Esmaeil Saberfar3 , Mahboubeh Hajiabdolbaghi4
1- Department of Virology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
2- Department of Nanobiotechnology, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran
3- Virology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran
4- AIDS Research Center, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran
2- Department of Nanobiotechnology, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran
3- Virology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran
4- AIDS Research Center, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran
Abstract: (6969 Views)
Objective: The use of antiretroviral drugs has proven remarkably effective in controlling the progression of human immunodeficiency virus (HIV) disease, but these benefits can be compromised by the development of drug resistance. This study aims to assess the drug resistance profile of the Pr gene in highly active antiretroviral therapy (HAART)-treated and naïve HIV-1 infected patients.
Methods: A total of 30 samples from naïve and 16 samples of highly active antiretroviral therapy (HAART)-treated patients were collected and divided into two groups. After RNA extraction, RT nested PCR was performed. The final products were sequenced and then analyzed for drug-resistant mutations and subtypes.
Results: No drug resistant mutations were noted in group one that have never used drug, but 40% of group two samples which are under treatment contained drug resistant mutations. According to the results, the following subtypes were seen among patients: A (50%), B (40.6%), D (6.2%), and C (3.2%).
Conclusion: Transmission of drug-resistant viruses and their detection are very important epidemiologically. However our data and other studies suggest that other PIs should be replaced by LPV in the HAART regime.
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |